Clinical Research would be a lot more difficult without the help of Clinical Research Organizations (CROs). These companies within the pharmaceutical industry not only help support drug companies but also companies in the biotechnology and medical device industries as well. Some…
A phase 3 study for chikungunya vaccine after passing midstage test
The chikungunya vaccine, known as MV-CHIK, hit its primary goal in the phase 2 trial, and Themis is now eyeing a move into phase 3. The company based its chikungunya shot on its measles vector platform, licensed from Institut Pasteur. In the…
A new way to prevent heart disease in Type 1 diabetes
Scientists reveal the mechanism which allows a commonly prescribed drug for Type 2 diabetes to prevent heart disease in patients with Type 1 diabetes and could lead to new treatments. Metformin is an inexpensive treatment that is often used for Type…
FOMAT Announces New Website Launch
A new design to improve the experience of our visitors. CALIFORNIA (Oct. 12th, 2018) — FOMAT Medical Research launches their newly redesigned website that offers a new experience to our visitors. The new website will allow visitors to learn more about…
Lupus Treatment Generates Positive Results in Phase III Clinical Trial
New research indicates that belimumab, a monoclonal antibody therapy that targets a component of the immune system, provides considerable benefits to patients with systemic lupus erythematosus (SLE), a predominately female, chronic inflammatory disease that can affect virtually any organ. The Arthritis &…
Personalized Tumor Vaccine Shows Promise in Pilot Trial
A new type of cancer vaccine harnesses tumor immunity has yielded promising results in an initial clinical trial conducted at the Perelman School of Medicine at the University of Pennsylvania and the Abramson Cancer Center of the University of Pennsylvania. The…
Forbes Nominates Nicholas Focil As Part Of The LA Business Council
[Los Angeles, CA. March 7, 2018] — [Fomat Medical Research CEO Nicholas Focil], [Clinical Research Network in the US and LatAm], has been accepted into the Forbes Los Angeles Business Council, the foremost growth and networking organization for small businesses in Greater…
FOMAT Medical Research Announces Joint Venture with the Hospital Teodoro Maldonado Carbo
FOMAT Medical Research, a pioneering clinical research company in Latin America, is honored to announce that it will embark on a joint venture with the hospital Teodoro Maldonado Carbo in Ecuador in order to provide clinical research services in the South…
FOMAT Medical Research Announces Joint Venture with Reumalab
Oxnard, CA, December 2017 – FOMAT Medical Research, a leading organization in clinical research, is launching a joint venture with Reumalab in order to provide clinical research services in Medellin, Colombia, that is set to improve clinical research outcomes in Latin…
5 ways to boost Minorities’ Participation in Clinical Trials
Minorities’ participation in clinical trials is often an issue of debate among the clinical research industry. Anyway, most of us agree that their participation is crucial in order to develop better treatments for everybody. That’s why as part of the professionals…